Last updated 2026-07-20
Total raised
—
Last: Undisclosed Round 2024-11
Stage
Mature
Founded
2024
Headcount
1-10
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Interna Therapeutics is a highly innovative Israeli bio-pharmaceutical company that develops a universal platform called Molecular Nano-Motors (MNMs) for delivering macromolecule drugs into cells using membrane electrical forces. The company is focused on infectious and non-infectious respiratory diseases and is also pursuing partnerships to license its technology to pharmaceutical companies. Interna Therapeutics was formed in November 2024 through the merger of Aposense Ltd. and its subsidiary SirVir.
Offices
Petah Tikva, Israel · HQ / main office
Q&A
- What is Interna Therapeutics' primary focus?
- Interna Therapeutics is an innovative biotechnology company focused on drug delivery via electrical nano motors, specifically developing Molecular Nano-Motors (MNMs) for macromolecule delivery.
- When was Interna Therapeutics founded?
- Interna Therapeutics was founded in October 1996.
- How many employees does Interna Therapeutics have?
- Interna Therapeutics has 11-50 employees.
- What is the total amount of funding Interna Therapeutics has raised to date?
- Interna Therapeutics has raised a total of $57,550,000 USD.
- When was Interna Therapeutics' most recent funding round, and who were the lead investors?
- Interna Therapeutics' most recent funding round occurred in November 2024, with the Bill & Melinda Gates Foundation as a lead investor.
- What is the status of Interna Therapeutics' COVID-19 drug development?
- A Phase I study for Interna Therapeutics' COVID-19 drug began in September 2024.
- What is Interna Therapeutics' core technology?
- Interna Therapeutics' core technology is Molecular Nano-Motors (MNMs), which leverage membrane electrical forces to facilitate the entry of charged molecules into cells for drug delivery.
- What types of diseases does Interna Therapeutics' technology aim to address?
- Interna Therapeutics' technology aims to provide new treatment options for a wide range of diseases by delivering difficult-to-deliver molecules such as oligonucleotide-based drugs (siRNA, ASO).
Team · 17
Jacob Gottenstein
Founder · Co-founder
Yuval Gottenstein
CEO
Guy Kornberg, Ph.D.
COO
Hagit Grimberg, Ph.D.
Executive VP, R&D
Joel Van Gelder, Ph.D.
Chief Innovation Officer
Etty Genis Barak
CFO
Carmit Lev
HR & Operations Manager
Harel Yaakovi
R&D Operations Coordinator
Prof. Roger D Kornberg
Scientific President
Prof. Alon Dumanis
Chairman of the Board
Hamutal Ben Dov, Ph.D.
Senior Scientist
Shira Bezaleli
Bookeeper & Salary Administrator
Prof. James Rothman
Chair of the SAB
Prof. Gary Schoolnik
Former head of Infectious Diseases, Stanford Hospital
Yossi Benamram
Former President of Merck Europe, Russia, Africa, ME
Prof. Yehuda Adler, M.D, M.H.A.
Director, Development of Medical Resources; Director, Talpiot Medical Leadership Program; Chairman, Sheba Internship Committee, The Chaim Sheba Medical Center, Tel Hashomer, Israel
Mr. Amos Bar Shalev
Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
BiologicalsMoleculesMaterials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
gastroenterologycns-disorderspulmonarycanceroncologyparkinsonpharmaceuticalsdrug-deliverygeneticsnanotechnologypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | interna.bio |
|---|---|
| linkedin.com/company/1833144 | |
| YouTube | youtube.com/user/Aposense |
Identifiers & details
| Former names | NST |
|---|---|
| Founded | 2024-11 |
| Employees (exact) | 19 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | interna.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512380296 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1996-10-09 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), shares_capital (1) |
| Registered address | אודם 5 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2025-09-07 | העברת מניות |